| 30.4.2009 | Calcitonin gene-related peptide 8-37 sem meðferð við psoriasis: Mat á stöðugleika og leit að hentugu lyfjaformi | Jón Pétur Guðmundsson 1984- |
| 21.4.2023 | Can previous use of benzodiazepines, Z-drugs, and opioids predict incident pregabalin use? | Sveinn Hlynur Tómasson 1998- |
| 21.4.2023 | Cannabidiol in Icelandic grown hemp: Extraction methods and analytical techniques | Kristófer Haukur Hauksson 1996- |
| 22.6.2020 | Chitosan coatings for surfaces to prevent implant-related infections | Una Guðmundsdóttir 1995- |
| 2.5.2012 | Chitosan Derivatives that mimic Antimicrobial Peptides. Synthesis, characterization and antimicrobial activity. Testing | Bjarni Már Óskarsson 1982- |
| 29.5.2020 | Chitosan-formylrifamycin conjugation by click chemistry | Árni Freyr Helgason 1994- |
| 17.12.2018 | Chitosan-natural antioxidant conjugates: Synthesis, antimicrobial and antioxidant properties | Nagy, Vivien, 1991- |
| 25.4.2022 | Chitotriazolan nanoparticles for drug delivery | Hilmar Már Gunnlaugsson 1997- |
| 13.5.2020 | Comparison of Different Assay Methods and Sample Preparation Procedures for the Evaluation of the Antibacterial Activity of Chitosan | Sigríður Ólafsdóttir 1991- |
| 19.4.2024 | Compression Coated Diphenhydramine tablets: Tablets with at least 8 hour zero-order drug release | Ásta Sóley Jónsdóttir 2001-; Hrafnhildur Kara Kristinsdóttir 1998-; Hlynur Orri Gunnarsson 2002- |
| 26.4.2019 | Content and distribution of usnic acid enantiomers in three Icelandic lichen taxa | Aron Elvar Gylfason 1993- |
| 3.5.2016 | Correction of Dystrophin gene with Homology Directed Repair | Guðjón Reykdal Óskarsson 1991- |
| 3.5.2016 | CRISPR/Cas9 for the Correction of Mutated Dystrophin Gene | Thapa, Priyanka, 1988- |
| 30.4.2012 | Determination of half maximal inhibitory concentration (IC50) of several anticancer drugs for inhibiting CYP3A4 metabolism of midazolam | Íris Stella Heiðarsdóttir 1987- |
| 29.4.2011 | Determination of hydrating effects of moisturizing creams containing Icelandic plant extracts | Þórdís Þorvarðardóttir 1984- |
| 2.5.2017 | Developing Multifunctional Selenium and Iron Oxide Nanocomposites for Targeted Cancer Applications | Halla Laufey Hauksdóttir 1991- |
| 25.4.2022 | Development and optimization of gelatin/chitosan membranes for use in wound treatment | Theodór Árni Mathiesen 1997- |
| 3.5.2011 | Development of a LC-MS/MS Method for the Quantification of Cortisol and Cortisone | Arndís Sue Ching Löve 1985- |
| 12.4.2022 | Development of a modified release formulation for diclofenac sodium tablets | Ástþór Ingi Hannesson 1998-; Bjarni Björnsson 2000-; Elizabeth Ósk Anjie Löve 2000-; Eyþór Jón Þórsson 1998- |
| 20.4.2021 | Development of a patch for hand osteoarthritis | Ástrós Óskarsdóttir 1996- |
| 17.5.2013 | Development of a sample preparation method for the detection and identification of cholesterol in a Parkinson’s disease model utilizing MALDI-MSI | Ingólfur Birgisson 1988- |
| 29.4.2019 | Development of an Erythromycin – Enzyme compatible formulation | Hólmfríður Gylfadóttir 1992- |
| 25.4.2022 | Development of an erythromycin-trypsin combination treatment for biofilm infections | Martin Janczewski 1996- |
| 25.4.2023 | Development of Aspirin Tablets with a Comparable Dissolution Profile to a Commercial Product | Una Þorsteinsdóttir 1999-; Jóhanna Lan 2001-; María Björk Pálsdóttir 2001- |
| 28.4.2020 | The development of buffering systems for the purification of biologics | Reynir Ágúst Guðbrandsson 1993- |
Íslenska
